N.J. Admin. Code § 8:21-3A.14

Current through Register Vol. 56, No. 12, June 17, 2024

Section 8:21-3A.14 - Due diligence

(a) Prior to the initial purchase or acquisition of prescription drugs from another wholesale distributor, a wholesale distributor shall obtain the following information from the selling wholesale distributor:

1. Copies of all state and Federal regulatory licenses and registrations;

2. The wholesaler distributor's most recent facility inspection reports;

3. A list of other names under which the wholesale distributor is doing business or by which the wholesale distributor was formally known;

4. A list of corporate officers and managerial employees and designated representative; and

5. A verification of the selling wholesale distributor's status as an authorized distributor of record, if applicable.

(b) At least annually, a wholesale distributor that purchases prescription drugs from another wholesale distributor shall update the information set forth in (a) above.

(c) No purchase shall take place from any storage facility, manufacturer or wholesale distributor not having a current license or registration within the jurisdiction of the establishment location from where product is purchased.

(d) No purchase or acquisition shall be permitted from a firm that has not provided complete information as set forth in (a) above.

N.J. Admin. Code § 8:21-3A.14

New Rule, R.2006 d.391, effective 11/20/2006.
See: 37 N.J.R. 3899(a), 38 N.J.R. 4857(b).
Section was "Reserved".